Drug recall · July 24, 2013
Piperacillin and Tazobactam for Injection recall
Why: Crystallization: Potential to exhibit precipitation/crystallization in IV bag or IV line upon reconstitution.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Piperacillin and Tazobactam for Injection, USP, 40.5 grams per Pharmacy Bulk Package vial, Rx only, Mfg. by: Hospira Healthcare India Pvt. Ltd., Irungattukottai - 602 105, India; Mfg. for: Apotex Corp., Weston, FL 33326, NDC 60505-0773-0.
- Lots / codes
Lot #: 503B015, 503B016, Exp 04/13; 503B019, 503B020, 503B021, 503B022, Exp 07/13; 503B024, Exp 08/13; 503B025, 503B026, 503B027, Exp 09/13; 503C005, 503C006, Exp 12/13; 503C007, 503C008, Exp 01/14; 503C018, Exp 04/14
- Quantity
- 37,303 vials
- Company
- Apotex Corp., Weston, FL
- Distribution
- Nationwide
- Initiated
- March 18, 2013 · Voluntary: Firm initiated
- Classified
- July 17, 2013
- Reported
- July 24, 2013
- Ended
- January 8, 2018
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.